In light of the recent nomination of Robert F. Kennedy Jr. as the Secretary of Health and Human Services by President Trump, there has been a significant focus on his proposed shift of funding from vaccine and infectious disease research to the prevention of chronic diseases. Such a stance is somewhat understandable given the colossal impact of chronic disease on not only individuals, their families, local communities, and healthcare providers, but also on the national economy and taxpayers.
However, this cursory glance can be misleading considering the proven interrelationship between chronic illnesses (those of a long-term nature) and acute diseases (those with a limited duration). Infectious disease treatments often prove to be a crucial preventative measure against the likelihood of suffering chronic infections in the longer term, highlighting the need for a concerted focus on both areas. The intimate link between funding for chronic and acute health conditions is a historical reality, becoming even more crucial in our public health domain.
A glimpse into the past showcases this significant correlation. In the pre-antibiotic era, about a hundred years ago, rheumatic fever was a primary cause of child mortality. This chronic condition was the outcome of untreated strep infections, subsequently developing into rheumatic heart disease. Such victims generally suffered a severely reduced lifespan due to heart damage. With the advent of penicillin in the late 1940s, rheumatic fever cases decreased dramatically, casting light on the bridge between an acute infection and a chronic disease. Today, rheumatic fever is largely considered preventable, adding weight to the importance of infectious disease research and treatment.
This connection also extends to conditions manifested as a result of untreated syphilis. Penicillin’s introduction restrained the emergence of chronic conditions such as neurosyphilis (general paresis), accounting for a quarter of psychiatric admissions, and other organ damage or severe complications during pregnancy, often leading to fetal and neonatal mortalities. However, contemporary times witness an alarming increase in syphilis rates due to funding redirection from sexually transmitted disease prevention.
As evidence piles up highlighting the strong bond between acute infections and chronic disease, it becomes increasingly imprudent to consider funding infectious and chronic disease research as a competition. History validates the role of combating infectious disease in reducing chronic illnesses. Simultaneously, chronic disease treatment and cure research are vital. A comprehensive public health strategy should embrace research across both realms.
Nearing the fifth anniversary of the COVID-19 pandemic, a fresh connection between infectious disease and chronic conditions comes into perspective with ‘long COVID’, now a primary focus for chronic disease research.
In conclusion, funding acute infectious disease research is proven to equip our healthcare systems better in preventing and managing chronic diseases.
Source: https://www.aol.com/opinion-infection-disease-becomes-chronic-160000160.html